Drug Profile
Brain-derived neurotrophic factor
Alternative Names: BDNF; Brain-derived growth factorLatest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Max Planck Institute of Experimental Medicine
- Developer Amgen; Medtronic; Regeneron Pharmaceuticals; Sumitomo Pharmaceuticals
- Class Nerve growth factors
- Mechanism of Action Neuron stimulants; TrkB receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis
Most Recent Events
- 02 Feb 2001 Discontinued-Clinical for Amyotrophic lateral sclerosis in Japan (SC)
- 02 Feb 2001 Discontinued-II for Amyotrophic lateral sclerosis in USA (Intrathecal)
- 02 Feb 2001 Discontinued-II for Amyotrophic lateral sclerosis in USA (SC)